Common Stock (Details Narrative) - USD ($) $ / shares in Units, $ in Thousands |
3 Months Ended | 12 Months Ended | |
---|---|---|---|
Dec. 27, 2021 |
Mar. 31, 2021 |
Dec. 31, 2021 |
|
Subsidiary, Sale of Stock [Line Items] | |||
Number of units sold | 2,585,000 | ||
Purchase price, per unit | $ 5.50 | ||
Exercise price | $ 5.50 | ||
Aggregate purchase price | $ 13,471 | ||
IPO [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Number of units sold | 2,585,000 | ||
Purchase price, per unit | $ 5.50 | ||
Exercise price | $ 5.50 | ||
Additional number of days | 45 days | ||
Additional shares of common stock issued | 387,750 | ||
Number of additional warrants issued | 387,750 | ||
Underwriter [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Value of common stock offered on initial closing date | 387,750 | ||
Private Placement [Member] | |||
Subsidiary, Sale of Stock [Line Items] | |||
Purchase price, per unit | $ 2.80 | ||
Issuances of common stock, net of issuance costs (in shares) | 101,800 | ||
Aggregate purchase price | $ 285 |
X | ||||||||||
- Definition Additional number of days. No definition available.
|
X | ||||||||||
- Definition Additional shares of common stock issued. No definition available.
|
X | ||||||||||
- Definition Agreement to issue common stock on initial closing date. No definition available.
|
X | ||||||||||
- Definition Units issued during period shares new issues. No definition available.
|
X | ||||||||||
- Definition Exercise price per share or per unit of warrants or rights outstanding. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Number of securities into which the class of warrant or right may be converted. For example, but not limited to, 500,000 warrants may be converted into 1,000,000 shares. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
X | ||||||||||
- Definition Per share or per unit amount of equity securities issued. No definition available.
|
X | ||||||||||
- Definition Number of new stock issued during the period. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Equity impact of the value of new stock issued during the period. Includes shares issued in an initial public offering or a secondary public offering. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. No definition available.
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|
X | ||||||||||
- Details
|